Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting

International Journal of Cancer

Volumn 136, Issue 6, 2015, Pages E743-E750

  Tebeu, Pierre Marie ^a   Fokom Domgue, Joël ^a,b   Crofts, Victoria ^b   Flahaut, Emmanuel ^b   Catarino, Rosa ^b   Untiet, Sarah ^b   Vassilakos, Pierre ^c   Petignat, Patrick ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

Author keywords

Accuracy; Cervical cancer screening; HPV testing; Low income setting; Sequential testing; Two stage strategy; VIA

Indexed keywords

ADULT; AGED; ARTICLE; CAMEROONIAN; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CURETTAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEMALE GENITAL TRACT CYTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INCOME; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VISUAL INSPECTION OF THE CERVIX WITH ACETIC ACID; BIOPSY; DIAGNOSTIC USE; EARLY DIAGNOSIS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ACETIC ACID;

ACETIC ACID; ADULT; BIOPSY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCOME; MIDDLE AGED; PAPILLOMAVIRIDAE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84922110582     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29250     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) - Human Papillomavirus and Related Cancers in Cameroon. Summary Report 2010, September 15, 2010.
3. Sankaranarayanan R, Thara S, Esmy PO, et al. Cervical cancer: screening and therapeutic perspectives. Med Principles Pract 2008;17:351-64.
4. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-9.
5. Robyr R, Nazeer S, Vassilakos P, et al. Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytol 2002;46:1110-6.
6. WHO DoRHaRDoCDaHP, ed. Comprehensive cervical cancer control - a guide to essential practice. Geneva: WHO, 2006.
7. Sauvaget C, Fayette JM, Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecology Obstet 2011;113:14-24.
8. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
9. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-101.
10. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012;104:178-88.
11. Petignat P, Vassilakos P. Is it time to introduce HPV self-sampling for primary cervical cancer screening? J Natl Cancer Inst 2012;104:166-7.
12. Franco EL. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening. J Natl Cancer Inst 2009;101:1600-1.
13. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-5.
14. Untiet S, Vassilakos P, McCarey C, et al. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy. Int J Cancer 2014;135:1911-7.
15. Womack SD, Chirenje ZM, Blumenthal PD, et al. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG 2000;107:33-8.
16. De Vuyst H, Claeys P, Njiru S, et al. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynaecol Obstet 2005;89:120-6.
17. Mahmud SM, Sangwa-Lugoma G, Nasr SH, et al. Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo. Gynecologic oncology. 2012;124:286-91.
18. Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008;123:153-60.
19. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO, 2013.
20. Sankaranarayanan R, Wesley RS. A practical manual on visual screening for cervical neoplasia. Lyon: IARCPress, 2003.
21. Franco EL. Statistical issues in human papillomavirus testing and screening. Clin Lab Med 2000;20:345-67.
22. Muwonge R, Manuel Mda G, Filipe AP, et al. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet 2010;111:68-72.
23. Ngoma T, Muwonge R, Mwaiselage J, et al. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 2010;109:100-4.
24. Jeronimo J, Bansil P, Lim J, et al. A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer 2014;24:576-85.
25. Denny L, Kuhn L, Pollack A, et al. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707.
26. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72.
27. Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstetrics Gynecol 2006;195:349-53.
28. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430-4.
29. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUSLSIL Triage Study. JAMA 2001;285:1500-5.
30. Wright TC, Ronnett BM, Kurman RJ, et al. Precancerous lesions of the cervix. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's pathology of the female genital tract, 6th edn., New York: Springer-Verlag, 2011. 193-252.
31. Gaffikin L, McGrath JA, Arbyn M, et al. Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis. BMC Med Res Methodol 2007;7:36.
32. Sangwa-Lugoma G, Mahmud S, Nasr SH, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006;119:1389-95.
33. Wright TC. Chapter 10: cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr 2003:66-71.
34. Blumenthal PD, Lauterbach M, Sellors JW, et al. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet 2005;89 Suppl 2:S30-7.
35. Blumenthal PD, McIntosh N. Cervical cancer prevention guidelines for low-resource settings. Baltimore: JHPIEGO, 2005.
36. Gravitt PE, Paul P, Katki HA, et al. Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India. PLoS One 2010;5:e13711.
37. Labani S, Asthana S, Sodhani P, et al. CareHPV cervical cancer screening demonstration in a rural population of north India. Eur J Obstet Gynecol Reprod Biol 2014;176:75-9.
38. Slawson DC, Bennett JH, Herman JM. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET study. Harrisburg Area Research Network. J Fam Pract 1992;35:271-7.
39. Hovland S, Arbyn M, Lie AK, et al. A comprehensive evaluation of the accuracy of cervical precancer detection methods in a high-risk area in East Congo. Br J Cancer 2010;102:957-65.
40. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000;83:561-5.
41. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11:249-57.
42. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26 Suppl 10:K29-41.
43. Blumenthal PD, Gaffikin L, Chirenje ZM, et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72:47-53.
44. Basu PS, Sankaranarayanan R, Mandal R, et al. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer 2003;13:626-32.
45. Lewis KC, Tsu VD, Dawa A, et al. A comparison of triage methods for Kenyan women who screen positive for cervical intraepithelial neoplasia by visual inspection of the cervix with acetic acid. Afr Health Sci 2011;11:362-9.
46. Rijkaart DC, Heideman DA, Coupe VM, et al. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology. J Clin Microbiol 2012;50:2390-6.
47. Pierry D, Weiss G, Lack B, et al. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age. Arch Pathol Lab Med 2012;136:956-60.
48. Qiao YL, Jeronimo J, Zhao FH, et al. Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer 2014;134:2891-901.